Shanghai Yizhong Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 34.34 million. Revenue was CNY 34.34 million.

Net income was CNY 30.74 million compared to net loss of CNY 5.5 million a year ago. Basic earnings per share from continuing operations was CNY 0.2132 compared to basic loss per share from continuing operations of CNY 0.0515 a year ago. Diluted earnings per share from continuing operations was CNY 0.2132 compared to diluted loss per share from continuing operations of CNY 0.0515 a year ago.